Navigation Links
Masimo to Present at Goldman Sachs 29th Annual Global Healthcare Conference
Date:6/3/2008

IRVINE, Calif., June 3 /PRNewswire-FirstCall/ -- Masimo Corporation (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through-Motion-and-Low-Perfusion pulse oximetry, today announced that it is scheduled to present at the Goldman Sachs 29th Annual Global Healthcare Conference at The Ritz Carlton, Laguna Nigel, in Dana Point, CA, on Wednesday, June 11, 2008, at 2:40 p.m. PT. Joe E. Kiani, Chairman and CEO, will be presenting.

A live audiocast of the presentation will be available on the Masimo website at http://www.masimo.com. A replay of the audiocast will be available following the live presentation.

About Masimo

Masimo (Nasdaq: MASI) develops innovative monitoring technologies that significantly improve patient care-helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through-Motion-and-Low-Perfusion pulse oximetry, known as Masimo SET, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced Masimo Rainbow SET, a breakthrough noninvasive blood constituent monitoring platform that can measure many blood constituents that previously required invasive procedures. Masimo Rainbow SET continuously and noninvasively measures total hemoglobin (SpHb(TM)), oxygen content (SpOC(TM)), carboxyhemoglobin (SpCO(R)), methemoglobin (SpMet(R)), and PVI(TM), in addition to oxyhemoglobin (SpO2), pulse rate (PR), and perfusion index (PI), allowing early detection and treatment of potentially life-threatening conditions. Founded in 1989, Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications." Additional information about Masimo and its products may be found at http://www.masimo.com.

Masimo, SET, Signal Extraction Technology, Improving Outcomes and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpCO, SpMet, PVI, Pulse CO-Oximetry and Pulse CO-Oximeter are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference
2. Masimo Reports First Quarter 2008 Financial Results
3. Atom Medical Adopts Masimo Rainbow SET Technology
4. Schiller AG Adopts Masimo Rainbow SET as Their Technology Platform of Choice for Patient Monitoring Devices Worldwide
5. Masimo to Present at Citi Investment Research 5th Annual Small & Mid-Cap Conference
6. Masimo Reports Fourth Quarter 2007 and Full Year 2007 Financial Results
7. Masimo Announces Continuous Noninvasive Total Hemoglobin
8. Masimo Awarded Multi-Year Pulse Oximetry Agreement with HealthTrust Purchasing Group
9. Abington Memorial Hospital Completes System-Wide Conversion to Masimo SET Pulse Oximetry Technology
10. Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan
11. Masimo to Report Third Quarter 2007 Financial Results on October 30, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... 2017  On January 10 at the Medtech Showcase ... Healthcare Conference in San Francisco , ... spoke to pharmaceutical leaders and public and private investors ... down and destroy biofilms.  Biofilms are ... and the body,s immune system from eradicating chronic infections. Infections ...
(Date:1/16/2017)... LOUISVILLE, Ky. , Jan. 16, 2017  Eurofins ... service, which will allow more customers to receive their ... price premium or compromise in quality found with other ... the United States at no additional ... variety of routine genetic studies, including DNA sequencing, genotyping, ...
(Date:1/13/2017)... Research and Markets has announced the addition of the "Global ... ... CAGR of 16.83% during the period 2017-2021. The report ... market for 2017-2021. To calculate the market size, the report considers the ... also includes a a discussion of the key vendors operating in this ...
(Date:1/12/2017)... , ... January 12, 2017 ... ... VTI’S INTERFUSE® IS A SUCCESS , VTI, Vertebral Technologies, Inc., announces the ... InterFuse® laterally expandable device. Since September 2016, VTI (Vertebral Technologies, Inc.) has ...
Breaking Biology Technology:
(Date:12/16/2016)... YORK , Dec. 16, 2016 The global wearable ... USD 12.14 billion by 2021 from USD 5.31 billion in 2016, ... ... is mainly driven by technological advancements in medical devices, launch of ... rising preference for wireless connectivity among healthcare providers, and increasing focus ...
(Date:12/15/2016)... ... and Markets has announced the addition of the "Global Military Biometrics ... forecasts the global military biometrics market to grow at a CAGR of ... prepared based on an in-depth market analysis with inputs from industry experts. ... coming years. The report also includes a discussion of the key vendors ...
(Date:12/15/2016)... 14, 2016 "Increase in mobile transactions is ... mobile biometrics market is expected to grow from USD ... 2022, at a CAGR of 29.3% between 2016 and ... the growing demand for smart devices, government initiatives, and ... "Software component is expected to grow at a high ...
Breaking Biology News(10 mins):